Nasdaq smmt.

Fiscal Q3 2023 ended 9/30/23. Reported on 11/7/23. Get the latest Summit Therapeutics Inc (SMMT) real-time quote, historical performance, charts, and other financial information to …3 de fev. de 2023 ... Summit Therapeutics (NASDAQ:SMMT) shares are plummeting over 40% on Friday morning. Gaucho Group Holdings (NASDAQ:VINO) stock is diving more ...Dec 1, 2023 · During the last session, Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares were 1.99 million, with the beta value of the company hitting -1.00. At the end of the trading day, the stock’s price was $2.03, reflecting an intraday gain of 4.10% or $0.08. The 52-week high for the SMMT share is $5 ... Summit Therapeutics Inc (NASDAQ:SMMT) 1.93 Delayed Data As of Nov 17 +0.07 / +3.76% Today’s Change 0.66 Today ||| 52-Week Range 5.78 -54.59% Year-to-Date Quote Profile News Charts Forecasts...

OXFORD, United Kingdom, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM) the drug discovery and development company advancing therapies for Duchenne muscular ...

Oxford, UK, and Cambridge, MA, US, 17 July 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today announced that it highlighted the potential of its preclinical new class antibiotic, SMT ...Cambridge, MA, November 6, 2020 – Summit (NASDAQ: SMMT) today announces that it has closed its previously announced private placement for a fundraising of $50 million (the “Fundraising ...

Nov 16, 2023 · The public float for SMMT is 111.77M and currently, short sellers hold a 8.48% ratio of that float. The average trading volume of SMMT on November 16, 2023 was 972.70K shares. SMMT) stock’s latest price update. The stock of Summit Therapeutics Inc (NASDAQ: SMMT) has increased by 0.51 when compared to last closing price of 1.97. OXFORD, United Kingdom, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM) announces further positive findings from PhaseOut DMD, a Phase 2 open-label, multi-centre ...Dec 4, 2023 · Bitdeer Technologies Holding Co (NASDAQ:BTDR)’s Major holders Insiders own 59.14% of the company shares, while shares held by institutions stand at 2.18% with a share float percentage of 5.33%. Investors are also buoyed by the number of investors in a company, with Bitdeer Technologies Holding Co having a total of 13 institutions that hold ... Find the latest Insider Activity data for Summit Therapeutics Inc. Common Stock (SMMT) at Nasdaq.com.

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Summit Therapeutics Inc. Common Stock (SMMT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Oxford, UK, and Cambridge, MA, US, 24 December 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) announces the exercise by Leopoldo Zambeletti, a Non-Executive Director of Summit, of ...Oxford, UK, and Cambridge, MA, US, 3 October 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today announced that it presented results from the Phase 2 clinical trial of ridinilazole in ...SMMT: SUMMIT THERAPEUTICS INC. veja seus indicadores fundamentalistas, variação ... NASDAQ. PART. S&P 500. PARTICIPAÇÃO NO S&P 500. 0 % arrow_forward. bookmarks ...Which Summit Therapeutics insiders have been buying company stock? The following insiders have purchased SMMT shares in the last 24 months: Ankur Dhingra ($217,390.39), Mahkam Zanganeh ($16,772,430.15), Manmeet Singh Soni ($4,999,999.20), and Robert W Duggan ($487,318,100.91).

LIESTAL, Switzerland, OXFORD, England and CAMBRIDGE, Mass., Dec. 06, 2017 (GLOBE NEWSWIRE) -- Santhera Pharmaceuticals (SIX:SANN), Summit Therapeutics (NASDAQ:SMMT) (AIM:SUMM), Catabasis ...SMMT: SUMMIT THERAPEUTICS INC. veja seus indicadores fundamentalistas, variação ... NASDAQ. PART. S&P 500. PARTICIPAÇÃO NO S&P 500. 0 % arrow_forward. bookmarks ...Phunware Inc (NASDAQ:PHUN)’s Major holders Insiders own 8.46% of the company shares, while shares held by institutions stand at 9.60% with a share float percentage of 10.48%. Investors are also buoyed by the number of investors in a company, with Phunware Inc having a total of 43 institutions that hold shares in the company.OXFORD, United Kingdom, Sept. 24, 2015 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular ...Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Web

Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call.

Cambridge, MA, October 2, 2020 – Summit (NASDAQ: SMMT) today announces that it has entered into a binding agreement with the Company’s Chief Executive Officer and Executive Chairman, ...Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...WebSummit Therapeutics Inc (NASDAQ:SMMT) shares are down by almost 13% year to date bringing their 12-month return to over 85%. As of this writing, Summit Therapeutics shares are trading at around $3.70 with a 52-week range of $0.66 to $5.78, giving the company a market capitalization of more than $835 million. PDS …WebDec 6, 2022 · Cambridge, Massachusetts-based biotech Summit Therapeutics (NASDAQ:SMMT) jumped ~38% pre-market Tuesday after announcing a collaboration and license agreement with Hong Kong-listed biopharma Akeso ... Oxford, UK, and Cambridge, MA, US, 19 December 2019 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), a leader in antibiotic innovation, announces that, further to the announcement made on 6 ...Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Oxford, UK, and Cambridge, MA, US, 14 April 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, today presented in vivo proof of concept ...

(SMMT). NASDAQ: SMMT · IEX Real-Time Price · USD. Add to Watchlist. 2.13. +0.10 (4.93%). Dec 1, 2023, 4:00 PM EST - Market closed. Overview · Financials ...

MENLO PARK, Calif., October 31, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that data for its novel, potential first-in-class investigational bispecific antibody, ivonescimab, will be presented at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) in San Diego, CA.

Dec 4, 2023 · Phunware Inc (NASDAQ:PHUN)’s Major holders Insiders own 8.46% of the company shares, while shares held by institutions stand at 9.60% with a share float percentage of 10.48%. Investors are also buoyed by the number of investors in a company, with Phunware Inc having a total of 43 institutions that hold shares in the company. Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2023 Earnings Call Transcript May 11, 2023 Operator: Good morning, and welcome to the Summit Therapeutics First Quarter 2023 Earnings and Update Call.Nov 3, 2021 · Follow. Cambridge, Massachusetts, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that Dr. Urte Gayko, PhD, has been appointed to our Board of Directors ... Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Cambridge, Massachusetts, and we have additional offices in Oxford, UK ...WebSummit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK.Phunware Inc (NASDAQ:PHUN) has a beta value of 10.36 and has seen 4.58 million shares traded in the recent trading session. The company, currently valued at $19.34M, closed the recent trade at $0.14 per share which meant it gained $0.01 on the day or 13.69% during that session. The PHUN stock price ...WebSummit Therapeutics Inc NASDAQ: SMMT is a biopharmaceutical company focused on discovering, developing, and commercializing antibiotics for serious infectious ...Summit Therapeutics Inc. Common Stock (SMMT) 0 Add to Watchlist Add to Portfolio SMMT SMMT INSIDER ACTIVITY SMMT Insider Activity Number of Insider Trades Data is …Fiscal Q3 2023 ended 9/30/23. Reported on 11/7/23. Get the latest Summit Therapeutics Inc (SMMT) real-time quote, historical performance, charts, and other financial information to …há 2 dias ... (NASDAQ:SMMT – Get Free Report)'s stock price dropped 3.9% during trading on Friday . The stock traded as low as $1.94 and last traded at ...Jun 22, 2022 · Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...

Oxford, UK, and Cambridge, MA, US, 5 September 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) presented in vivo proof of concept data for its targeted Enterobacteriaceae antibiotics in ...Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call ... Oxford, UK, and Cambridge, MA, US, 15 January 2020 - Summit Therapeutics (AIM: SUMM, NASDAQ: SMMT), a leader in antibiotic innovation, announces that it has received notification that on 14 ...Instagram:https://instagram. phone insurance comparisonhawaii mortgage lendersprivate investment platformswhat is the best dental plan in florida Summit Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. SMMT updated stock price target summary.Data is delayed at least 15 minutes. Nasdaq.com will report pre-market and after hours trades. Pre-Market trade data will be posted from 4:15 a.m. ET to 7:30 a.m. ET of the following day. After ... forex system tradinggood 10 dollar stocks Oxford, UK, and Cambridge, MA, US, 9 July 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today announces that it has demonstrated the potential of its DDS-04 series of new class ...OXFORD, United Kingdom, March 30, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular ... day trading td ameritrade Oxford, UK, and Cambridge, MA, US, 14 April 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader in new mechanism antibiotic innovation, today presented in vivo proof of concept ...Summit Therapeutics Inc Ordinary Shares SMMT Morningstar Rating Unlock Stock XNAS Rating as of Dec 1, 2023 Summary Chart News Price vs Fair Value …